Clinical trial
Phase IV Study of Optimal Stenting Strategy For True Bifurcation Lesions
NCT00693251 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV Study of Optimal Stenting Strategy For True Bifurcation Lesions
- Lead sponsor
- Seung-Jung Park
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- June 30, 2015
- Enrollment
- 420 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.